Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05635266
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:34.312447+00:00
Published At
2024-05-07T00:00:00+00:00
Record Updated At
2024-05-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Age-Related Macular Degeneration", "Allergies", "Alpha-Gal Syndrome", "Alzheimer Disease", "Amyloidosis", "Ankylosing Spondylitis", "Arthritis", "Alopecia Areata", "Asthma", "Atopic Dermatitis", "Autism", "Autoimmune Hepatitis", "Behcet\u0027s Disease", "Beta-Thalassemia", "Cancer", "Celiac Disease", "Kidney Diseases", "COPD", "Crohn Disease", "Cystic Fibrosis", "Diabetes", "Dravet Syndrome", "DMD", "Fibromyalgia", "Graves Disease", "Thyroid Diseases", "Hepatitis", "Hidradenitis Suppurativa", "ITP", "Leukemia", "ALS", "Lupus or SLE", "Lymphoma", "Multiple Sclerosis", "Myasthenia Gravis", "Heart Diseases", "Parkinson Disease", "Pemphigus Vulgaris", "Cirrhosis", "Psoriasis", "Schizophrenia", "Scleroderma", "Sickle Cell Disease", "Stroke", "Ulcerative Colitis", "Vasculitis", "Vitiligo"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-05-07"
protocolSection.identificationModule.nctId
"NCT05635266"
protocolSection.identificationModule.officialTitle
"A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
[]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Age-Related Macular Degeneration (protocolSection.conditionsModule.conditions)
  • Allergies (protocolSection.conditionsModule.conditions)
  • Alpha-Gal Syndrome (protocolSection.conditionsModule.conditions)
  • Alzheimer Disease (protocolSection.conditionsModule.conditions)
  • Amyloidosis (protocolSection.conditionsModule.conditions)
  • Ankylosing Spondylitis (protocolSection.conditionsModule.conditions)
  • Arthritis (protocolSection.conditionsModule.conditions)
  • Alopecia Areata (protocolSection.conditionsModule.conditions)
  • Asthma (protocolSection.conditionsModule.conditions)
  • Atopic Dermatitis (protocolSection.conditionsModule.conditions)
  • Autism (protocolSection.conditionsModule.conditions)
  • Autoimmune Hepatitis (protocolSection.conditionsModule.conditions)
  • Behcet's Disease (protocolSection.conditionsModule.conditions)
  • Beta-Thalassemia (protocolSection.conditionsModule.conditions)
  • Cancer (protocolSection.conditionsModule.conditions)
  • Celiac Disease (protocolSection.conditionsModule.conditions)
  • Kidney Diseases (protocolSection.conditionsModule.conditions)
  • COPD (protocolSection.conditionsModule.conditions)
  • Crohn Disease (protocolSection.conditionsModule.conditions)
  • Cystic Fibrosis (protocolSection.conditionsModule.conditions)
  • Diabetes (protocolSection.conditionsModule.conditions)
  • Dravet Syndrome (protocolSection.conditionsModule.conditions)
  • DMD (protocolSection.conditionsModule.conditions)
  • Fibromyalgia (protocolSection.conditionsModule.conditions)
  • Graves Disease (protocolSection.conditionsModule.conditions)
  • Thyroid Diseases (protocolSection.conditionsModule.conditions)
  • Hepatitis (protocolSection.conditionsModule.conditions)
  • Hidradenitis Suppurativa (protocolSection.conditionsModule.conditions)
  • ITP (protocolSection.conditionsModule.conditions)
  • Leukemia (protocolSection.conditionsModule.conditions)
  • ALS (protocolSection.conditionsModule.conditions)
  • Lupus or SLE (protocolSection.conditionsModule.conditions)
  • Lymphoma (protocolSection.conditionsModule.conditions)
  • Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Myasthenia Gravis (protocolSection.conditionsModule.conditions)
  • Heart Diseases (protocolSection.conditionsModule.conditions)
  • Parkinson Disease (protocolSection.conditionsModule.conditions)
  • Pemphigus Vulgaris (protocolSection.conditionsModule.conditions)
  • Cirrhosis (protocolSection.conditionsModule.conditions)
  • Psoriasis (protocolSection.conditionsModule.conditions)
  • Schizophrenia (protocolSection.conditionsModule.conditions)
  • Scleroderma (protocolSection.conditionsModule.conditions)
  • Sickle Cell Disease (protocolSection.conditionsModule.conditions)
  • Stroke (protocolSection.conditionsModule.conditions)
  • Ulcerative Colitis (protocolSection.conditionsModule.conditions)
  • Vasculitis (protocolSection.conditionsModule.conditions)
  • Vitiligo (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.